Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma

J. Weber, M. Mandala, M. Del Vecchio, H.J. Gogas, A.M. Arance, C.L. Cowey, S. Dalle, M. Schenker, V. Chiarion-Sileni, I. Marquez-Rodas, J.-J. Grob, M.O. Butler, M.R. Middleton, M. Maio, V. Atkinson, P. Queirolo, R. Gonzalez, R.R. Kudchadkar, M. Smylie, N. MeyerL. Mortier, M.B. Atkins, G.V. Long, S. Bhatia, C. Lebbé, P. Rutkowski, K. Yokota, N. Yamazaki, T.M. Kim, V. De Pril, J. Sabater, A. Qureshi, J. Larkin, P.A. Ascierto, Massimo Guidoboni

Research output: Contribution to journalArticlepeer-review

Original languageItalian
Pages (from-to)1824-1835
Number of pages12
JournalNew England Journal of Medicine
Volume377
Issue number19
DOIs
Publication statusPublished - 2017

Cite this